Literature DB >> 9840543

Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: a case report.

J Gallardo, M Fodor, C Gamargo, L Orlandi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9840543     DOI： 10.1002/(sici)1097-0142(19981201)83:11<2419::aid-cncr23>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.

Authors:  Jae-Yong Cho; Ji-Sun Nam; Mi-Suk Park; Jeong-Sik Yu; Yong-Han Paik; Se-Joon Lee; Dong-Ki Lee; Dong-Sup Yoon
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

2.  Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors.

Authors:  Brian A Costello; Mitesh J Borad; Yingwei Qi; George P Kim; Donald W Northfelt; Charles Erlichman; Steven R Alberts
Journal:  Invest New Drugs       Date:  2014-04-18       Impact factor: 3.850

3.  Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943.

Authors:  Steven R Alberts; Jonathan R Sande; Nathan R Foster; Fernando J Quevedo; Robert R McWilliams; John W Kugler; Tom R Fitch; Anthony J Jaslowski
Journal:  J Gastrointest Cancer       Date:  2008-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.